- Home
- IMCR vs CBRL Comparison
IMCR vs CBRL Comparison
Compare IMCR & CBRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- CBRL
- Stock Information
- Founded
- IMCR 2008
- CBRL 1969
- Country
- IMCR United Kingdom
- CBRL United States
- Employees
- IMCR N/A
- CBRL N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- CBRL Restaurants
- Sector
- IMCR Health Care
- CBRL Consumer Discretionary
- Exchange
- IMCR Nasdaq
- CBRL Nasdaq
- Market Cap
- IMCR 1.5B
- CBRL 1.2B
- IPO Year
- IMCR 2021
- CBRL N/A
- Fundamental
- Price
- IMCR $31.34
- CBRL $59.60
- Analyst Decision
- IMCR Buy
- CBRL Hold
- Analyst Count
- IMCR 10
- CBRL 8
- Target Price
- IMCR $58.13
- CBRL $53.86
- AVG Volume (30 Days)
- IMCR 560.7K
- CBRL 1.2M
- Earning Date
- IMCR 08-07-2025
- CBRL 06-05-2025
- Dividend Yield
- IMCR N/A
- CBRL 1.70%
- EPS Growth
- IMCR N/A
- CBRL N/A
- EPS
- IMCR N/A
- CBRL 2.58
- Revenue
- IMCR $333,581,000.00
- CBRL $3,510,062,000.00
- Revenue This Year
- IMCR $26.82
- CBRL $1.97
- Revenue Next Year
- IMCR $8.15
- CBRL $1.61
- P/E Ratio
- IMCR N/A
- CBRL $22.89
- Revenue Growth
- IMCR 25.75
- CBRL 2.84
- 52 Week Low
- IMCR $23.15
- CBRL $33.86
- 52 Week High
- IMCR $41.54
- CBRL $65.43
- Technical
- Relative Strength Index (RSI)
- IMCR 40.28
- CBRL 58.36
- Support Level
- IMCR $35.10
- CBRL $51.95
- Resistance Level
- IMCR $37.56
- CBRL $60.68
- Average True Range (ATR)
- IMCR 1.74
- CBRL 3.35
- MACD
- IMCR -0.79
- CBRL -0.11
- Stochastic Oscillator
- IMCR 0.75
- CBRL 80.61
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About CBRL Cracker Barrel Old Country Store Inc
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. The restaurants of the company are open for breakfast, lunch, and dinner, with menus that offer home-style country food. The company generates maximum revenue from the Restaurants.